FDA Inspection 825626 — Noven Pharmaceuticals, Inc.
The FDA completed an inspection of Noven Pharmaceuticals, Inc. on Mar 6, 2013 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 6, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)